{
  "docId": "019de077-6f73-7101-bfe0-7e9b852b36c0",
  "docSlug": "8dcc88c54610c972f3bae6a00c8c2119",
  "documentTitle": "MindMed | Investor Presentation Deck | 28 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 28,
  "prevPage": 27,
  "nextPage": null,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a structured list format to map specific clinical trial risks to mitigation strategies.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-6f73-7101-bfe0-7e9b852b36c0/28",
  "deckHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0",
  "deckJsonHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0.json",
  "deckAnchorHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.16,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "image",
      "text": "Expectancy Bias & Functional Unblinding; Cardiovascular Safety; Adverse Event Collection",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfe41545-cded-49b3-9972-3aee9c603f44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.7,
        "x": 0.22,
        "y": 0.15
      },
      "kind": "list",
      "text": "Independent central raters blinded to treatment and visit number for primary outcome measure; Dose-response in Phase 2b across 'functionally active' doses; Complementary studies with multiple 'functionally masking' arms; Pre- and post-dose expectancy assessment (participants); Post-dose (participant) and rating (raters) blinding assessment; Drug effect isolated from psychotherapeutic intervention",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1488a916-c194-45b2-91da-6b5c3e40ce01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.22,
        "y": 0.75
      },
      "kind": "list",
      "text": "Collection of all AEs, including “positive” and MOA-related; Frequent assessment to define time course for resolution of drug effects",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72ff7d65-e4bc-43cd-8da1-c1d85a07752c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.22,
        "y": 0.58
      },
      "kind": "list",
      "text": "Collection of ECGs in Phase 3 Clinical Trials; Dedicated TQT study in parallel with Phase 3",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b35f7da-6c70-4032-a9ab-29c93ce79bfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.16,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "AE: adverse event; ECG: electrocardiogram; MOA: mechanism of action; TQT: thorough QT",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fe19a65-fc00-48b5-ae32-2668dd764a7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Strategies to Address Key Drug Class Methodological Considerations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7c06d61-162f-42bd-a05b-d6ba1694f392",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}